Edward I Chang1, Jesse Jun Liu1. 1. Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract
INTRODUCTION: Covid-19 has ushered in drastic changes to the healthcare system in order to "flatten the curve"; in particular, surgical operations that can consume vital, limited resources, not to mention the risk to staff, anesthesiologists, and surgeons. However, under unique circumstances with diligent preparation, vital oncologic operations can be performed safely. METHODS: Prospective comparison of surgical cases during the pandemic from December 2019 to May 2020 to the correlating time frame from December 2018 to May 2019. RESULTS: A significant decline in case volume was not appreciated until the United States declared a national state of emergency, allowing patients with cancer to continue to undergo curative tumor resection until then (428.3 ± 51.5 vs 166.6 ± 59.8 cases/week; P < .001). The decrease was consistent with the mean case volume during the holidays (213.8 ± 76.8 vs 166.6 ± 59.8 case/week; P = .648). Evaluation of surgical subspecialties demonstrated a significant decrease for all subspecialties with the greatest decline in sarcoma (P = .002) and endocrine (P = .001) surgeries, while vascular (P = .004) and thoracic (P = .011) surgeries had the least. CONCLUSIONS: The novel coronavirus has drastically reduced oncologic operations, but with proper evaluation of patients and allocation of resources, surgery can be performed safely without compromising the aim to flatten the curve and control the coronavirus pandemic.
INTRODUCTION:Covid-19 has ushered in drastic changes to the healthcare system in order to "flatten the curve"; in particular, surgical operations that can consume vital, limited resources, not to mention the risk to staff, anesthesiologists, and surgeons. However, under unique circumstances with diligent preparation, vital oncologic operations can be performed safely. METHODS: Prospective comparison of surgical cases during the pandemic from December 2019 to May 2020 to the correlating time frame from December 2018 to May 2019. RESULTS: A significant decline in case volume was not appreciated until the United States declared a national state of emergency, allowing patients with cancer to continue to undergo curative tumor resection until then (428.3 ± 51.5 vs 166.6 ± 59.8 cases/week; P < .001). The decrease was consistent with the mean case volume during the holidays (213.8 ± 76.8 vs 166.6 ± 59.8 case/week; P = .648). Evaluation of surgical subspecialties demonstrated a significant decrease for all subspecialties with the greatest decline in sarcoma (P = .002) and endocrine (P = .001) surgeries, while vascular (P = .004) and thoracic (P = .011) surgeries had the least. CONCLUSIONS: The novel coronavirus has drastically reduced oncologic operations, but with proper evaluation of patients and allocation of resources, surgery can be performed safely without compromising the aim to flatten the curve and control the coronavirus pandemic.
Authors: Amjad Soltany; Mohammed Hamouda; Ansam Ghzawi; Ahmed Sharaqi; Ahmed Negida; Shaimaa Soliman; Amira Yasmine Benmelouka Journal: Ann Med Surg (Lond) Date: 2020-07-09
Authors: Aviva S Mattingly; Liam Rose; Hyrum S Eddington; Amber W Trickey; Mark R Cullen; Arden M Morris; Sherry M Wren Journal: JAMA Netw Open Date: 2021-12-01
Authors: Linda Gifford; Christine C Johnson; Nadia Haque; Karla D Passalacqua; Jennifer Swiderek; Steven Kalkanis Journal: Int J Health Plann Manage Date: 2021-12-02
Authors: Ziad Bakouny; Jessica E Hawley; Toni K Choueiri; Solange Peters; Brian I Rini; Jeremy L Warner; Corrie A Painter Journal: Cancer Cell Date: 2020-10-01 Impact factor: 38.585